1. Ma, Junting, Yang, Yaping, Fu, Yong, Zhang, Junfeng, Chen, Jiangning. 2018. PIAS3-mediated feedback loops promote chronic colitis-associated malignant transformation. In Theranostics, 8, 3022-3037. doi:10.7150/thno.23046. https://pubmed.ncbi.nlm.nih.gov/29896300/
2. Zhao, Huanhuan, Liu, Dan, Sun, Sha, Yu, Yonghao, Xu, Zhelong. 2024. PIAS3 acts as a zinc sensor under zinc deficiency and plays an important role in myocardial ischemia/reperfusion injury. In Free radical biology & medicine, 221, 188-202. doi:10.1016/j.freeradbiomed.2024.05.025. https://pubmed.ncbi.nlm.nih.gov/38750767/
3. Iwasaki, Kenta, Hailemariam, Kiros, Tsuji, Yoshiaki. 2007. PIAS3 interacts with ATF1 and regulates the human ferritin H gene through an antioxidant-responsive element. In The Journal of biological chemistry, 282, 22335-43. doi:. https://pubmed.ncbi.nlm.nih.gov/17565989/
4. Abbas, Rime, McColl, Karen S, Kresak, Adam, Wildey, Gary, Dowlati, Afshin. 2015. PIAS3 expression in squamous cell lung cancer is low and predicts overall survival. In Cancer medicine, 4, 325-32. doi:10.1002/cam4.372. https://pubmed.ncbi.nlm.nih.gov/25573684/
5. He, Tian, McColl, Karen, Sakre, Nneha, Wildey, Gary, Dowlati, Afshin. 2018. Post-transcriptional regulation of PIAS3 expression by miR-18a in malignant mesothelioma. In Molecular oncology, 12, 2124-2135. doi:10.1002/1878-0261.12386. https://pubmed.ncbi.nlm.nih.gov/30259640/
6. Nakagawa, Koji, Kohara, Toshihisa, Uehata, Yasuko, Takeda, Hiroshi, Kobayashi, Masanobu. 2015. PIAS3 enhances the transcriptional activity of HIF-1α by increasing its protein stability. In Biochemical and biophysical research communications, 469, 470-6. doi:10.1016/j.bbrc.2015.12.047. https://pubmed.ncbi.nlm.nih.gov/26697750/
7. Zhou, Jing, Bian, Huiying, Wu, Nan. 2023. Protein inhibitor of activated STAT3 (PIAS3) attenuates psoriasis and associated inflammation. In The Journal of dermatology, 50, 1262-1271. doi:10.1111/1346-8138.16874. https://pubmed.ncbi.nlm.nih.gov/37392066/
8. Dabir, Snehal, Kluge, Amy, Kresak, Adam, Wildey, Gary, Dowlati, Afshin. 2014. Low PIAS3 expression in malignant mesothelioma is associated with increased STAT3 activation and poor patient survival. In Clinical cancer research : an official journal of the American Association for Cancer Research, 20, 5124-32. doi:10.1158/1078-0432.CCR-14-1233. https://pubmed.ncbi.nlm.nih.gov/25124686/